BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BRYN - US0846707026 - Common Stock
412.65 EUR
-2.2 (-0.53%)
BRYN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Financial Services industry. BRYN has only an average score on both its financial health and profitability. BRYN may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make BRYN suitable for value investing!
1. Profitability
1.1 Basic Checks
- BRYN had positive earnings in the past year.
- BRYN had a positive operating cash flow in the past year.
- BRYN had positive earnings in 4 of the past 5 years.
- BRYN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- BRYN's Return On Assets of 5.50% is fine compared to the rest of the industry. BRYN outperforms 78.33% of its industry peers.
- With a decent Return On Equity value of 9.66%, BRYN is doing good in the industry, outperforming 63.33% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 4.53%, BRYN is in line with its industry, outperforming 56.67% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for BRYN is significantly below the industry average of 10.51%.
- The last Return On Invested Capital (4.53%) for BRYN is above the 3 year average (4.13%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.5% | ||
| ROE | 9.66% | ||
| ROIC | 4.53% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
1.3 Margins
- BRYN has a Profit Margin of 18.13%. This is in the better half of the industry: BRYN outperforms 71.67% of its industry peers.
- In the last couple of years the Profit Margin of BRYN has declined.
- Looking at the Operating Margin, with a value of 16.72%, BRYN is in line with its industry, outperforming 56.67% of the companies in the same industry.
- In the last couple of years the Operating Margin of BRYN has grown nicely.
- BRYN has a Gross Margin of 17.71%. This is in the lower half of the industry: BRYN underperforms 60.00% of its industry peers.
- BRYN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.72% | ||
| PM (TTM) | 18.13% | ||
| GM | 17.71% |
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
2. Health
2.1 Basic Checks
- BRYN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, BRYN has less shares outstanding
- Compared to 5 years ago, BRYN has less shares outstanding
- The debt/assets ratio for BRYN has been reduced compared to a year ago.
2.2 Solvency
- BRYN has an Altman-Z score of 1.36. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
- BRYN has a Altman-Z score (1.36) which is comparable to the rest of the industry.
- The Debt to FCF ratio of BRYN is 6.58, which is on the high side as it means it would take BRYN, 6.58 years of fcf income to pay off all of its debts.
- BRYN's Debt to FCF ratio of 6.58 is in line compared to the rest of the industry. BRYN outperforms 58.33% of its industry peers.
- BRYN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
- With a decent Debt to Equity ratio value of 0.18, BRYN is doing good in the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 6.58 | ||
| Altman-Z | 1.36 |
ROIC/WACC1.41
WACC3.22%
2.3 Liquidity
- A Current Ratio of 1.33 indicates that BRYN should not have too much problems paying its short term obligations.
- BRYN's Current ratio of 1.33 is in line compared to the rest of the industry. BRYN outperforms 53.33% of its industry peers.
- BRYN has a Quick Ratio of 1.11. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.11, BRYN is in line with its industry, outperforming 48.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.11 |
3. Growth
3.1 Past
- BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.97%, which is quite good.
- Measured over the past years, BRYN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.78% on average per year.
- BRYN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.60%.
- BRYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.84% yearly.
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%
3.2 Future
- BRYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.26% yearly.
- BRYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.89% yearly.
EPS Next Y-0.33%
EPS Next 2Y0.31%
EPS Next 3Y1.09%
EPS Next 5Y2.26%
Revenue Next Year0.8%
Revenue Next 2Y0.25%
Revenue Next 3Y1.4%
Revenue Next 5Y4.89%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 0.01, which indicates a rather cheap valuation of BRYN.
- 100.00% of the companies in the same industry are more expensive than BRYN, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.32. BRYN is valued rather cheaply when compared to this.
- The Price/Forward Earnings ratio is 0.01, which indicates a rather cheap valuation of BRYN.
- Based on the Price/Forward Earnings ratio, BRYN is valued cheaper than 100.00% of the companies in the same industry.
- BRYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.01 | ||
| Fwd PE | 0.01 |
4.2 Price Multiples
- BRYN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRYN is cheaper than 93.33% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, BRYN is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.04 | ||
| EV/EBITDA | 0.64 |
4.3 Compensation for Growth
- BRYN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.31%
EPS Next 3Y1.09%
5. Dividend
5.1 Amount
- BRYN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:BRYN (1/21/2026, 5:29:21 PM)
412.65
-2.2 (-0.53%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-01 2025-11-01/bmo
Earnings (Next)02-20 2026-02-20/bmo
Inst Owners26.93%
Inst Owner ChangeN/A
Ins Owners37.74%
Ins Owner ChangeN/A
Market Cap594.22M
Revenue(TTM)372.13B
Net Income(TTM)67.46B
Analysts44
Price Target447.83 (8.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.5%
Min EPS beat(2)0.19%
Max EPS beat(2)4.81%
EPS beat(4)3
Avg EPS beat(4)9.5%
Min EPS beat(4)-9.78%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.01%
EPS beat(12)8
Avg EPS beat(12)5.87%
EPS beat(16)12
Avg EPS beat(16)8.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)0.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)0.72%
Revenue beat(8)3
Avg Revenue beat(8)-1.35%
Revenue beat(12)5
Avg Revenue beat(12)-0.47%
Revenue beat(16)6
Avg Revenue beat(16)-0.84%
PT rev (1m)0.02%
PT rev (3m)-1.53%
EPS NQ rev (1m)-4.39%
EPS NQ rev (3m)-1.73%
EPS NY rev (1m)0.12%
EPS NY rev (3m)3.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.01 | ||
| Fwd PE | 0.01 | ||
| P/S | 0 | ||
| P/FCF | 0.04 | ||
| P/OCF | 0.02 | ||
| P/B | 0 | ||
| P/tB | 0 | ||
| EV/EBITDA | 0.64 |
EPS(TTM)28940.32
EY7013.28%
EPS(NY)28306.64
Fwd EY6859.72%
FCF(TTM)11443.4
FCFY2773.15%
OCF(TTM)23328.5
OCFY5653.34%
SpS220346.37
BVpS413395.17
TBVpS342552
PEG (NY)N/A
PEG (5Y)0
Graham Number518831
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.5% | ||
| ROE | 9.66% | ||
| ROCE | 5.61% | ||
| ROIC | 4.53% | ||
| ROICexc | 4.87% | ||
| ROICexgc | 5.82% | ||
| OM | 16.72% | ||
| PM (TTM) | 18.13% | ||
| GM | 17.71% | ||
| FCFM | 5.19% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexgc growth 3Y9.15%
ROICexgc growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 6.58 | ||
| Debt/EBITDA | 1.69 | ||
| Cap/Depr | 151.95% | ||
| Cap/Sales | 5.39% | ||
| Interest Coverage | 12.22 | ||
| Cash Conversion | 52.22% | ||
| Profit Quality | 28.65% | ||
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.11 | ||
| Altman-Z | 1.36 |
F-Score4
WACC3.22%
ROIC/WACC1.41
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
EPS Next Y-0.33%
EPS Next 2Y0.31%
EPS Next 3Y1.09%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%
Revenue Next Year0.8%
Revenue Next 2Y0.25%
Revenue Next 3Y1.4%
Revenue Next 5Y4.89%
EBIT growth 1Y15.71%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.02%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-12.66%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%
BERKSHIRE HATHAWAY INC-CL B / BRYN.DE FAQ
Can you provide the ChartMill fundamental rating for BERKSHIRE HATHAWAY INC-CL B?
ChartMill assigns a fundamental rating of 5 / 10 to BRYN.DE.
What is the valuation status of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?
ChartMill assigns a valuation rating of 8 / 10 to BERKSHIRE HATHAWAY INC-CL B (BRYN.DE). This can be considered as Undervalued.
What is the profitability of BRYN stock?
BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) has a profitability rating of 6 / 10.
What are the PE and PB ratios of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?
The Price/Earnings (PE) ratio for BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 0.01 and the Price/Book (PB) ratio is 0.
How financially healthy is BERKSHIRE HATHAWAY INC-CL B?
The financial health rating of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 5 / 10.